ANCA Profile Test: What It Detects, What It Cannot, and How to Read Your Report

Key takeaways

• Supportive, not standalone: the ANCA profile is interpreted alongside symptoms, urine tests, kidney function, imaging and often a tissue biopsy.
• Two main antibodies matter most: PR3-ANCA and MPO-ANCA, measured by immunoassay; the immunofluorescence pattern (c-ANCA or p-ANCA) is a screening description.
• False positives occur: infections, some drugs, inflammatory bowel disease and other autoimmune conditions can produce ANCA positivity without vasculitis.
• A negative result is not an all-clear: a proportion of people with biopsy-proven vasculitis, particularly limited or eosinophilic forms, are ANCA-negative.
• Titres are not a treatment dial: rising or falling antibody levels correlate imperfectly with disease activity and should never trigger self-directed medicine changes.

At a glance

Also known as

• Antineutrophil cytoplasmic antibody profile
• ANCA panel, ANCA screen, "ANCA test" or "vasculitis blood test"
• c-ANCA / p-ANCA test
• PR3-ANCA and MPO-ANCA antibody test
• Anti-proteinase 3 and anti-myeloperoxidase antibody test

What the ANCA profile test is

Neutrophils are a type of white blood cell. In some autoimmune diseases, the immune system makes antibodies against proteins inside neutrophils. These antibodies are called ANCA. The ANCA profile test detects and measures them.

Two laboratory approaches are usually combined:

• Indirect immunofluorescence (IIF): stained neutrophils are examined under a microscope. A diffuse cytoplasmic glow is reported as c-ANCA; staining around the nucleus is reported as p-ANCA. This pattern reading is operator-dependent and subjective, and atypical or mixed patterns are common.
• Antigen-specific immunoassays: these measure antibodies against defined targets, PR3 (proteinase 3), usually linked with the c-ANCA pattern, and MPO (myeloperoxidase), usually linked with the p-ANCA pattern. Current international practice favours antigen-specific PR3 and MPO assays as the primary test for suspected ANCA-associated vasculitis, with immunofluorescence as a supporting method. Confirm the current guideline edition your laboratory follows.

A p-ANCA pattern without PR3 or MPO antibodies is fairly common and is often unrelated to vasculitis, it is seen in inflammatory bowel disease, autoimmune liver disease, chronic infections and some drug reactions.

Why the ANCA profile test is done

• Suspected ANCA-associated vasculitis: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic granulomatosis with polyangiitis (EGPA) and renal-limited vasculitis.
• Unexplained kidney injury: particularly rapidly worsening kidney function with blood and protein in the urine.
• Lung-kidney presentations: coughing blood together with abnormal kidney tests.
• Persistent upper airway disease: destructive nasal crusting, bloody nasal discharge, nasal bridge collapse, chronic sinus disease not responding to standard treatment, hearing loss.
• Multisystem illness: unexplained fever, weight loss, purpuric rash, numbness or weakness from nerve involvement, eye inflammation.
• Known vasculitis under follow-up: as one input when relapse is suspected.

Who should get this test

The ANCA profile is a targeted test, not a screening test for the general public or a routine part of a health check-up. It is appropriate when a doctor suspects small-vessel vasculitis. Typical candidates include people with:

• Fast-declining kidney function with an active urine sediment (red cells, red cell casts, protein).
• Alveolar haemorrhage or unexplained lung infiltrates and nodules, especially with anaemia.
• Chronic destructive sinonasal or ear disease with systemic symptoms.
• Late-onset asthma with high eosinophil counts, nerve symptoms or rash, raising the possibility of EGPA.
• Mononeuritis multiplex, palpable purpura or unexplained skin ulcers.
• Established ANCA-associated vasculitis with new symptoms suggesting relapse.

Ordering ANCA for vague tiredness or non-specific aches has a low yield and raises the chance of a misleading positive result.

What the ANCA profile test cannot detect or exclude

• It cannot confirm vasculitis. ANCA positivity supports the diagnosis but does not establish it. Confirmation usually needs the clinical picture plus histology (kidney, lung, nasal or skin biopsy) where feasible.
• It cannot exclude vasculitis. ANCA-negative disease exists, and is relatively more common in limited GPA and in EGPA, where a substantial proportion of patients are ANCA-negative. A negative ANCA describes what the assay did not find, it is not a clearance certificate.
• It cannot show which organs are affected or how badly. The antibody level does not measure kidney function, lung damage or nerve involvement. Urine examination, serum creatinine, imaging, nerve studies and biopsy do that work.
• It cannot distinguish active disease from remission on its own. Some people remain persistently ANCA-positive while in stable remission; others relapse with stable or negative antibody levels.
• It cannot identify other vasculitides. ANCA is not expected to be positive in large-vessel vasculitis (Takayasu, giant cell arteritis), IgA vasculitis, polyarteritis nodosa or Beh鏴t disease.
• It cannot separate vasculitis from infection reliably. Infective endocarditis and tuberculosis can mimic vasculitis clinically and occasionally produce ANCA positivity, an important consideration in India.
• It cannot detect anti-GBM (Goodpasture) disease, which needs a separate anti-GBM antibody test and can coexist with ANCA positivity.

If symptoms continue despite a normal ANCA profile, go back to your doctor rather than assuming the problem has been settled.

Related but different examinations

These tests answer different questions and are frequently ordered together rather than instead of one another.

How to prepare

Preparation for the ANCA profile is straightforward, but sample handling, fasting rules and appointment timings are operational decisions made by each laboratory. Your own unit's written instructions take precedence over any general guidance here.

• Fasting: usually not required for the ANCA profile. If it is bundled with other tests such as lipids or glucose, the lab may ask you to fast.
• Medicines: carry a full list, including steroids, immunosuppressants, hydralazine, propylthiouracil, cocaine or levamisole-adulterated substances, anti-tubercular drugs, and any AYUSH, herbal or gym supplement you take. Do not start, stop or change any prescribed medicine before the test, speak to the prescriber.
• Recent illness: tell the requesting doctor about any recent fever, infection or dental procedure, as this affects interpretation.
• Hydration: normal fluid intake makes the blood draw easier. If you have heart failure, advanced chronic kidney disease or a doctor-advised fluid restriction, do not increase fluids on the basis of general advice, follow your own limit.
• Blood thinners and bleeding disorders: mention these so the phlebotomist can apply pressure for longer.

If you are pregnant

The ANCA profile is a simple blood test and is performed during pregnancy when clinically indicated. Management of vasculitis in pregnancy needs joint obstetric and rheumatology or nephrology input, because several drugs used in vasculitis are unsuitable in pregnancy.

Children

ANCA-associated vasculitis occurs in children, though less often. Paediatric blood sampling uses smaller volumes and a paediatric phlebotomy setup; interpretation should be by a paediatric rheumatologist or nephrologist.

Older adults and people with fragile veins

Bruising is more likely. Tell the staff if you bruise easily or have had difficult draws before.

People already on immunosuppressive treatment

Ongoing steroids, cyclophosphamide, rituximab or other agents can lower measured antibody levels, so a negative or falling result in this setting should not be read as proof that disease is inactive.

What happens during the test

• Check-in: identity and test request are verified, and tubes are labelled.
• Site preparation: the skin over a vein, usually inside the elbow, is cleaned and a tourniquet applied briefly.
• Blood collection: a needle is inserted and a small sample collected into a plain or serum-separator tube.
• After the draw: pressure is applied for a minute or two and a small dressing placed.
• Laboratory step: serum is separated and tested by immunoassay, and by immunofluorescence where the lab includes it.

How long the process takes

• The blood draw: typically two to five minutes.
• The whole visit: commonly 15-30 minutes, depending on queues.
• Reporting: ANCA testing is often batched or referred to a specialised immunology laboratory, so reporting takes longer than routine blood tests. Ask your own laboratory for its reporting schedule, as this varies by facility and by whether the sample is tested in-house or referred.

Understanding your ANCA report

An ANCA report usually has two layers: a pattern result and an antigen-specific result. Different laboratories use different assay platforms and different units, so read the result against the reference range printed on your own report and not against a range found online.

• Negative for PR3 and MPO antibodies: no significant antibody detected by that assay. This lowers the probability of ANCA-associated vasculitis but does not exclude it, especially in EGPA and limited disease.
• PR3-ANCA positive (often with a c-ANCA pattern): more often associated with granulomatosis with polyangiitis, and with upper airway, lung and orbital involvement.
• MPO-ANCA positive (often with a p-ANCA pattern): more often associated with microscopic polyangiitis and renal-limited vasculitis, and also seen in some cases of EGPA and drug-associated vasculitis.
• p-ANCA pattern positive but PR3 and MPO negative: frequently a non-vasculitic finding. Inflammatory bowel disease, autoimmune hepatitis, primary sclerosing cholangitis, chronic infection and some drugs can produce this.
• Numerical levels or titres: a higher level makes vasculitis more likely than a borderline level, but there is no level that confirms disease and no cut-off that safely excludes it. Levels track disease activity imperfectly.

No result on this report is a diagnosis. The doctor who requested the ANCA profile will interpret it together with your symptoms, examination, urine findings, kidney function, imaging and, where needed, biopsy. Results vary depending on individual clinical circumstances.

When ANCA results can be misleading

Falsely raised or clinically irrelevant positives

• Infections: infective endocarditis, tuberculosis, chronic bacterial or fungal infection, and some viral illnesses can produce ANCA positivity. In India, tuberculosis and culture-negative endocarditis are important mimics that must be considered before immunosuppression.
• Other autoimmune disease: lupus, rheumatoid arthritis, autoimmune liver disease and inflammatory bowel disease can be ANCA-positive without ANCA-associated vasculitis.
• Drugs and substances: hydralazine, propylthiouracil and other antithyroid drugs, minocycline, and levamisole-adulterated cocaine are recognised causes of drug-associated ANCA positivity, often with high MPO levels.
• Assay and pattern issues: a positive ANA can interfere with immunofluorescence pattern reading and create an apparent p-ANCA. Pattern reading is subjective and varies between observers.
• Low-level or borderline positives: in people with a low prior probability of vasculitis, a weak positive is more likely to be a false lead than a real finding.

Falsely lowered or negative results

• Immunosuppressive treatment: steroids, cyclophosphamide, rituximab, azathioprine, mycophenolate and methotrexate can suppress measurable antibody.
• Truly ANCA-negative vasculitis: a real subset of disease, particularly EGPA and localised GPA.
• Assay platform differences: a sample negative on one manufacturer's assay can be positive on another. Serial monitoring is most meaningful when done on the same platform in the same laboratory.
• Very early disease: antibody may be undetectable at first presentation and appear later.

Risks and safety

Routine venous blood draw

Discomfort at the needle site, small bruise, brief light-headedness, and rarely a small collection of blood under the skin. Infection at the site is uncommon.

People on anticoagulants or with bleeding disorders

Bruising and prolonged oozing are more likely, and firmer, longer pressure over the site is needed. Mention these conditions before the draw.

Repeat monitoring draws

People under long-term follow-up have multiple draws over time; rotating sites and keeping well hydrated reduce vein irritation.

No radiation, contrast or sedation is involved in the ANCA profile test.

Special situations

Pregnancy

ANCA-associated vasculitis in pregnancy carries risks to both mother and baby and needs shared care between obstetrics and a rheumatologist or nephrologist. Several standard drugs, including cyclophosphamide and methotrexate, are unsuitable in pregnancy; any change must come from the prescriber, not from a test result alone.

Children and adolescents

Paediatric presentations may be dominated by kidney or airway disease. Growth, vaccination status and steroid effects on bone all need specialist paediatric oversight.

Older adults

MPO-ANCA disease is relatively more common in older adults and often presents with kidney involvement. Infection risk from immunosuppression is higher, so distinguishing relapse from infection is critical and cannot be done on ANCA levels alone.

Chronic kidney disease and dialysis

Many people are first diagnosed with vasculitis when they present with advanced kidney failure. ANCA testing is still useful, but treatment decisions rest on biopsy findings, dialysis dependence and overall condition. Do not increase fluid intake before a blood draw if you are on a fluid restriction.

Heart failure

Fluid and salt advice given for other purposes should not override your cardiologist's restriction. Breathlessness in this group may be cardiac rather than vasculitic and needs assessment, not assumption.

Diabetes on glucose-lowering therapy

If the ANCA profile is bundled with a fasting test, prolonged fasting can cause low blood sugar in people on insulin or sulfonylureas. Ask the prescriber how to time medicines around the test, and take glucose with you.

Suspected infection mimicking vasculitis

Because tuberculosis and endocarditis can imitate vasculitis and occasionally trigger ANCA positivity, doctors often obtain blood cultures, chest imaging and TB evaluation before starting immunosuppression.

The ANCA profile test in the Indian context

• Infection mimics are a genuine everyday problem. Tuberculosis, including extrapulmonary TB, and culture-negative infective endocarditis produce fever, weight loss, lung shadows, haematuria and raised inflammatory markers. Immunosuppressing such a patient on the strength of an ANCA result alone can cause serious harm.
• Drug and supplement exposure: propylthiouracil for thyroid disease, hydralazine, minocycline, and unregulated herbal, AYUSH or gym supplements are all worth declaring. Anti-tubercular therapy does not cause ANCA positivity but does cause abnormal liver tests that may confuse the overall picture.
• Nomenclature on Indian reports: laboratories may label the test "ANCA profile", "c-ANCA/p-ANCA", "PR3/MPO antibody" or "vasculitis panel". These are broadly the same family of tests but the exact components differ, so check what your report actually includes.
• Testing logistics: ANCA is not available in every small laboratory and samples are often referred to a central immunology laboratory. Ask where the sample will be tested, since serial monitoring is most reliable when repeated on the same platform.
• Data protection: personal health information collected through hospital forms, portals or online booking tools is handled under the Digital Personal Data Protection Act 2023.
• Access to specialists: ANCA-associated vasculitis needs rheumatology or nephrology follow-up, which is concentrated in larger cities. Planning follow-up and drug monitoring before starting treatment matters, particularly for patients travelling from smaller towns.

Cost and insurance in India

Prices for the ANCA profile vary widely between laboratories and cities, and any figure quoted online should be confirmed directly with the laboratory before the test. Cost is influenced by:

• Panel composition: pattern-only immunofluorescence costs less than a panel that also includes quantitative PR3 and MPO immunoassays.
• Assay technology: ELISA, chemiluminescence and fluoroenzyme immunoassay platforms are priced differently.
• In-house versus referred testing: referral to a central laboratory adds logistics cost.
• Bundling: vasculitis work-ups often include ANA, anti-dsDNA, anti-GBM, complement, hepatitis serology, urine studies and imaging, each adding to the total.
• Setting: outpatient sampling, home collection and inpatient testing are billed differently.
• Repeat testing: monitoring means recurring costs over months or years.

Insurance: outpatient investigations are often not covered unless the policy includes an OPD or diagnostics benefit. When testing is part of a hospital admission for vasculitis, it is usually considered within the admission claim, subject to policy terms, waiting periods and pre-existing disease clauses. Check with your insurer or the hospital's insurance desk before testing.

Myths and facts

Frequently asked questions

What does the ANCA profile test actually measure?

The ANCA profile measures antibodies directed against proteins inside neutrophils, chiefly PR3 and MPO, and may also report an immunofluorescence pattern described as c-ANCA or p-ANCA. The result supports or weakens the suspicion of ANCA-associated vasculitis, but interpretation depends entirely on symptoms and other test findings.

Do I need to fast before the ANCA profile test?

Fasting is not usually required for the ANCA profile test itself, as antibody levels are not affected by food. Fasting may be requested if the same blood draw includes tests such as glucose or lipids. Follow the written instruction from your own laboratory, which takes precedence.

Can a positive ANCA result occur without vasculitis?

Yes. Infective endocarditis, tuberculosis, inflammatory bowel disease, autoimmune liver disease, lupus and drugs such as hydralazine, propylthiouracil and minocycline can all produce ANCA positivity. Low-level positives in people without suggestive symptoms are particularly likely to be clinically unimportant and need careful clinical review.

What is the difference between ANCA and ANA?

The ANCA profile targets neutrophil proteins and is used mainly when small-vessel vasculitis is suspected. The ANA test targets nuclear components and is used mainly when lupus or another connective tissue disease is suspected. They answer different questions and are sometimes both ordered together.

Should ANCA be repeated regularly if I have vasculitis?

Many specialists repeat ANCA during follow-up, but the level alone does not decide treatment. Some people stay persistently positive while in remission, and relapse can occur without a rise. Monitoring relies on symptoms, urine testing, kidney function and inflammatory markers alongside the antibody level.

Can medicines change my ANCA result?

Yes. Immunosuppressive drugs including steroids, cyclophosphamide, rituximab, azathioprine and mycophenolate can lower measurable antibody, while certain other drugs can trigger positivity. Never adjust a prescribed medicine before or after testing, discuss any concerns with the doctor who prescribed it.

Does a normal ANCA profile mean my kidneys are fine?

No. The ANCA profile says nothing about kidney function. Serum creatinine, estimated GFR, urine routine and microscopy, and urine protein measurement assess the kidneys. A normal ANCA with abnormal urine findings still needs nephrology assessment and may require a kidney biopsy.

Why did my report show p-ANCA positive but PR3 and MPO negative?

This combination is common and frequently unrelated to vasculitis. It is seen in inflammatory bowel disease, autoimmune hepatitis, primary sclerosing cholangitis and chronic infection, and can also reflect interference from other antibodies on immunofluorescence. Your doctor will decide whether further evaluation is warranted.

Is a biopsy still needed if ANCA is strongly positive?

Often yes. Biopsy of kidney, lung, nasal tissue or skin confirms the diagnosis, shows how active and how chronic the disease is, and helps predict recovery of organ function. In some urgent situations treatment is started before biopsy, but that decision belongs to the treating specialist.

Sources

• Jennette JC et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis & Rheumatism.
• Bossuyt X et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nature Reviews Rheumatology.
• American College of Rheumatology / EULAR classification criteria for granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis, 2022.
• EULAR recommendations for the management of ANCA-associated vasculitis (2022 update). Annals of the Rheumatic Diseases.
• KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases, 2021, ANCA-associated vasculitis chapter.